Gan to kagaku ryoho. Cancer & chemotherapy

Sasaki K, Fujimoto T.
PMID: 3800407
Gan To Kagaku Ryoho. 1987 Jan;14(1):27-37.

The biological characteristics and prognosis of childhood malignant lymphoma were reviewed. A national survey of 568 cases of childhood malignant lymphoma in Japan revealed that 505 cases (88.9%) were non-Hodgkin's lymphoma (NHL), and 63 cases (11.1%) were Hodgkin's lymphoma...

Cancer

Meyers PA, Potter VP, Wollner N, Exelby P.
PMID: 4005797
Cancer. 1985 Jul 15;56(2):259-61. doi: 10.1002/1097-0142(19850715)56:2<259::aid-cncr2820560209>3.0.co;2-1.

In the last 5 years we have seen six cases of bowel perforation during initial therapy for childhood non-Hodgkin's lymphoma (NHL). Perforation occurred only in patients with Stage III or IV disease. It occurred in patients without clinically detectable...

The American journal of pediatric hematology/oncology

Gasparini M, Lombardi F, Gianni C, Lattuada A, Rilke F, Fossati-Bellani F.
PMID: 6412581
Am J Pediatr Hematol Oncol. 1983;5(2):161-71.

Seventy-nine consecutive children with non-Hodgkin's lymphoma were treated with a uniform intensive radiotherapy-chemotherapy program including high-dose MTX and CNS prophylaxis. Burkitt-type NHL was diagnosed in 44% and convoluted cell-type NHL in 33%. Complete remission rate was 97.5%. Forty-eight of...

The Turkish journal of pediatrics

Büyükpamukçu M, Ilhan I, Cağlar M, Akyüz C, Berberoğlu S, Kotiloğlu E.
PMID: 7597762
Turk J Pediatr. 1995 Apr-Jun;37(2):117-23.

This study was performed to present our clinical experience with patients with cutaneous malignant lymphoma. Eight of 856 (1%) patients admitted to Hacettepe University Pediatric Oncology Department were diagnosed with skin involvement of non-Hodgkin's lymphoma between November 1971 and...

British journal of cancer

Atra A, Imeson JD, Hobson R, Gerrard M, Hann IM, Eden OB, Carter RL, Pinkerton CR.
PMID: 10780517
Br J Cancer. 2000 Apr;82(8):1396-402. doi: 10.1054/bjoc.1999.1083.

From July 1990 to March 1996, 112 children with stage III or IV B-cell non-Hodgkin's lymphoma (B-NHL) with up to 70% FAB L3-type blasts (n = 42) in the bone marrow without central nervous system (CNS) disease were treated...

Annals of hematology

Mohammadianpanah M, Omidvai S, Mosalei A, Ahmadloo N.
PMID: 15042316
Ann Hematol. 2005 Apr;84(4):223-6. doi: 10.1007/s00277-004-0860-0. Epub 2004 Mar 23.

Primary extranodal non-Hodgkin's lymphomas of the head and neck account for 10-20% of all non-Hodgkin's lymphomas. Primary tonsillar lymphoma accounts for less than 1% of head and neck malignancies, although the tonsil is the most common primary extranodal site...

Pediatrics international : official journal of the Japan Pediatric Society

Foley RW, Aworanti OM, Gorman L, McGovern B, O'Sullivan M, Smith OP, Twomey E, Gillick J.
PMID: 26670157
Pediatr Int. 2016 Apr;58(4):304-7. doi: 10.1111/ped.12807. Epub 2015 Dec 16.

Non-Hodgkin's lymphoma (NHL) is a relatively common childhood cancer that can present in a myriad of ways. It is essential that NHL is included in the differential diagnosis of children presenting with an abdominal complaint, especially those with unexplained...

Clinical radiology

Mitchell CD, Gordon I, Chessells JM.
PMID: 3486737
Clin Radiol. 1986 May;37(3):257-61. doi: 10.1016/s0009-9260(86)80331-2.

T-cell lymphoblastic malignancy in childhood includes both T-cell acute lymphoblastic leukemia (T-ALL) and non-Hodgkin's lymphoblastic lymphoma (T-NHL). There is considerable overlap between these disorders, which probably represent two ends of the same disease spectrum. To determine whether there are...

Cancer investigation

Cotelingam JD, Witebsky FG, Hsu SM, Blaese RM, Jaffe ES.
PMID: 3910193
Cancer Invest. 1985;3(6):515-22. doi: 10.3109/07357908509039813.

The type and incidence of malignant lymphoma developing in patients with the Wiskott-Aldrich syndrome being followed at the National Cancer Institute (NCI) between the years 1966 and 1982 was evaluated. Histologic material from lymphoid tissue was available for review...

Srpski arhiv za celokupno lekarstvo

Jancić-Nedeljkov R, Janković S, Mihaljević B, Milivojević G, Petrović M, Sretenović M.
PMID: 9863405
Srp Arh Celok Lek. 1998 Sep-Oct;126(9):345-8.

INTRODUCTION: The Working Formulation Classification (for clinical use) divides non-Hodgkin's lymphoma (NHL), according to the nature of the disease and response to therapy into the low, medium and high risk lymphomas. Although these subgroups include different pathohistological types of...

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Vannier JP.
PMID: 3191204
Biomed Pharmacother. 1988;42(4):263-9.

Childhood non-Hodgkin's lymphomas (NHL) are a heterogeneous group. Biological studies have shown that most mediastinal NHL are lymphoblastic lymphomas which are T-cell tumors. In contrast, most NHL occurring in the gastrointestinal tract, abdominal cavity and Waldeyer's ring are diffuse...

European journal of cancer & clinical oncology

Sumer T, Al-Awamy B, Al-Mouzan M.
PMID: 4076286
Eur J Cancer Clin Oncol. 1985 Oct;21(10):1191-4. doi: 10.1016/0277-5379(85)90014-8.

Twenty-five children with previously untreated stage IV non-Hodgkin's lymphoma (NHL) were studied. At the time of evaluation 16 patients were disease-free (64%), with a median observation time of 23 months. Intensive chemotherapy for childhood NHL provides a better outlook...